Please assess the completion status of the following clinical trial:

Trial Title: Efficacy of Seven-day Combined Rabeprazole Plus Levofloxacin Plus Augmentin for Eradication of Helicobacter Pylori

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patient proved with infection of H. pylori in gastric mucosa~* Patient with signed informed consent.~Exclusion Criteria:~* woman in breast feeding or pregnancy.~* allergy or severe adverse effects to drugs used in study.~* severe complications of peptic ulcer disease (like perforation or obstruction).~* patients with history of cancer or failure of major organs.

- Gender: ALL
- Minimum Age: 20 Years
- Maximum Age: 95 Years
- Healthy Volunteers: f

Study Arms:
- Levofloxacin-Amoxicillin/clavulanate (Type: EXPERIMENTAL): 7-day levofloxacin, amoxicillin/clavulanate, rabeprazole for Hp eradication.
- Clarithromycin-Amoxicillin (Type: ACTIVE_COMPARATOR): 7-day clarithromycin, amoxicillin, rabeprazole for Hp eradication.

Based on this trial design, predict the completion outcome and termination type (if applicable).